Friday, May 1, 2026

Migrant Rampage: Chinese Man Assaults Three Koreans and Steals Car in Wild Crime Spree

A Chinese man assaulted three South Koreans, stole a car, and caused a hit-and-run, resulting in multiple charges in Seoul.

U.S. Strategy Shift: How North Korea Gains Strategic Leverage Amid Military Rivalry

U.S. strategy shifts may fuel an arms race, empowering North Korea's influence and complicating security dynamics in the region.

Wang Yi’s Diplomatic Mission to North Korea: Enhancing Ties Before Key U.S.-China Talks

Wang Yi's visit to North Korea signals strategic talks to strengthen ties ahead of upcoming U.S.-China summit.

Jung Eun Kim

Author's Latest

Boehringer Ingelheim’s People Promise: How HR Innovation is Shaping the Future of Work in Asia

Boehringer Ingelheim emphasizes a people-centered strategy, focusing on talent mobility, leadership development, and diversity in the Asia-Pacific region.

How Daewoong, Naver, and J&P Medi are Transforming Digital Health: Key Insights from the 2026 Partners Day

The event showcases 10 startups presenting innovations in digital healthcare, focusing on AI, brain health, and business strategies.

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Celltrion Launches Omlyclo in Brazil: How This First Mover is Revolutionizing Autoimmune Treatment

Celltrion launched Omlyclo in Brazil, aiming to boost market penetration and strengthen ties with local medical professionals.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

Yuhan Corporation Partners with Huinno: A Game Changer for AI-Based ECG Monitoring in the U.S. Market

Yuhan Corporation partners with Huey No for a strategic agreement to enter the U.S. digital healthcare market.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

How Huons and Sanofi’s Vaccine Partnership Will Transform the Korean Market in 2026

Huons partners with Sanofi to distribute five vaccines in South Korea, enhancing access and leveraging cold chain logistics for better healthcare.

Samchundang Pharm Announces 250 Billion KRW Stake Sale…Expectations Rise for Future Growth

Samchundang Pharm's CEO plans a 2.5 billion KRW share sale for tax purposes, hinting at significant news and future growth in pharma.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.